Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Parathyroid Diseases 1Ovarian Neoplasms 1Neoplasms 1Melanoma 1Margins of Excision 1Inflammatory Breast Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Ovarian Epithelial 1Adenoma 1

Interventions

pembrolizumab 15Cisplatin 7Cetuximab 5dostarlimab 3Surveys and Questionnaires 3Carboplatin 3fludarabine 2abemaciclib 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Nivolumab 2Interviews as Topic 2Fulvestrant 2Docetaxel 2Cyclophosphamide 2Blood Specimen Collection 2130-nm albumin-bound paclitaxel 2ulixertinib 1trastuzumab deruxtecan 1toripalimab 1tislelizumab 1ribociclib 1repotrectinib 1patritumab deruxtecan 1palbociclib 1osimertinib 1olaparib 1niraparib 1nimotuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Indocyanine Green × 30 days × Clear all
NCT07149207 2026-05-12

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Medical University of South Carolina

Phase 2 Recruiting
30 enrolled
Head & Neck

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡